Back to search

Article

Integrative In Silico Transcriptomic and Pharmacogenomic Analysis of CD276 as a Candidate Prognostic Biomarker and Therapeutic Target in Bladder Cancer

2026-02-02

Abstract excerpt

<title>Abstract</title> <p>Despite recent advances in bladder cancer treatment, therapeutic resistance remains a critical challenge, necessitating the identification of novel molecular targets. This study used an integrative in silico approach to evaluate the prognostic value and molecular landscape of the immune regulatory molecule CD276 (B7-H3). Analyses of TCGA and GTEx datasets showed that CD276 is significan...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
805cca98-e8e0-5388-85b5-f3d146eacd6b
DOI
10.21203/rs.3.rs-8563890/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrative In Silico Transcriptomic and Pharmacogenomic Analysis of CD276 as a Candidate Prognostic Biomarker and Therapeutic Target in Bladder CancerDOI 10.21203/rs.3.rs-8563890/v1
Select a neighboring publication to make it the new centre.